Request for Covid-19 Impact Assessment of this Report

Healthcare

United States Drugs for Malaria Market by Manufacturers, States, Type and Application, Forecast to 2022

  • GLO1246958
  • 115 Pages
  • June 2017
  • Healthcare
Download Sample    Get Discount   
 
Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.

Scope of the Report:

This report focuses on the Drugs for Malaria in United States market, to split the market based on manufacturers, states, type and application.

Market Segment by Manufacturers, this report covers

Cipla

Guilin Pharmaceutical

IPCA Laboratories

GlaxoSmithKline

Mylan Labs

Roche

Novartis

Sanofi Aventis

Ajanta Pharma

Market Segment by States, covering

California

Texas

New York

Florida

Illinois

Market Segment by Type, covers

Aryl Aminoalcohol Compounds

Antifolate Compounds

Artemisinin Compounds

Market Segment by Applications, can be divided into

Prevention

Treatment

Other

There are 17 Chapters to deeply display the United States Drugs for Malaria market.

Chapter 1, to describe Drugs for Malaria Introduction, product type and application, market overview, market analysis by States, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Drugs for Malaria, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the United States market by States, covering California, New York, Texas, Illinois and Florida, with sales, price, revenue and market share of Drugs for Malaria, for each state, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8, 9, 10 and 11, to analyze the key States by Type and Application, covering California, New York, Texas, Illinois and Florida, with sales, revenue and market share by types and applications;

Chapter 12, Drugs for Malaria market forecast, by States, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022;

Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 15, to describe sales channel, distributors, traders, dealers etc.

Chapter 16 and 17, to describe Drugs for Malaria Research Findings and Conclusion, Appendix, methodology and data source.

Table of Contents

1 Market Overview

1.1 Drugs for Malaria Introduction

1.2 Market Analysis by Type

1.2.1 Aryl Aminoalcohol Compounds

1.2.2 Antifolate Compounds

1.2.3 Artemisinin Compounds

1.3 Market Analysis by Applications

1.3.1 Prevention

1.3.2 Treatment

1.3.3 Other

1.4 Market Analysis by States

1.4.1 California Status and Prospect (2012-2022)

1.4.2 Texas Status and Prospect (2012-2022)

1.4.3 New York Status and Prospect (2012-2022)

1.4.4 Florida Status and Prospect (2012-2022)

1.4.5 Illinois Status and Prospect (2012-2022)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Cipla

2.1.1 Profile

2.1.2 Drugs for Malaria Type and Applications

2.1.2.1 Type 1

2.1.2.2 Type 2

2.1.3 Cipla Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.1.4 Business Overview

2.1.5 Cipla News

2.2 Guilin Pharmaceutical

2.2.1 Profile

2.2.2 Drugs for Malaria Type and Applications

2.2.2.1 Type 1

2.2.2.2 Type 2

2.2.3 Guilin Pharmaceutical Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2.4 Business Overview

2.2.5 Guilin Pharmaceutical News

2.3 IPCA Laboratories

2.3.1 Profile

2.3.2 Drugs for Malaria Type and Applications

2.3.2.1 Type 1

2.3.2.2 Type 2

2.3.3 IPCA Laboratories Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3.4 Business Overview

2.3.5 IPCA Laboratories News

2.4 GlaxoSmithKline

2.4.1 Profile

2.4.2 Drugs for Malaria Type and Applications

2.4.2.1 Type 1

2.4.2.2 Type 2

2.4.3 GlaxoSmithKline Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4.4 Business Overview

2.4.5 GlaxoSmithKline News

2.5 Mylan Labs

2.5.1 Profile

2.5.2 Drugs for Malaria Type and Applications

2.5.2.1 Type 1

2.5.2.2 Type 2

2.5.3 Mylan Labs Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5.4 Business Overview

2.5.5 Mylan Labs News

2.6 Roche

2.6.1 Profile

2.6.2 Drugs for Malaria Type and Applications

2.6.2.1 Type 1

2.6.2.2 Type 2

2.6.3 Roche Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6.4 Business Overview

2.6.5 Roche News

2.7 Novartis

2.7.1 Profile

2.7.2 Drugs for Malaria Type and Applications

2.7.2.1 Type 1

2.7.2.2 Type 2

2.7.3 Novartis Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7.4 Business Overview

2.7.5 Novartis News

2.8 Sanofi Aventis

2.8.1 Profile

2.8.2 Drugs for Malaria Type and Applications

2.8.2.1 Type 1

2.8.2.2 Type 2

2.8.3 Sanofi Aventis Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8.4 Business Overview

2.8.5 Sanofi Aventis News

2.9 Ajanta Pharma

2.9.1 Profile

2.9.2 Drugs for Malaria Type and Applications

2.9.2.1 Type 1

2.9.2.2 Type 2

2.9.3 Ajanta Pharma Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9.4 Business Overview

2.9.5 Ajanta Pharma News

3 United States Drugs for Malaria Market Competition, by Manufacturer

3.1 United States Drugs for Malaria Sales and Market Share by Manufacturer (2016-2017)

3.2 United States Drugs for Malaria Revenue and Market Share by Manufacturer (2016-2017)

3.3 United States Drugs for Malaria Price by Manufacturers (2016-2017)

3.4 Market Concentration Rate

3.4.1 Top 3 Drugs for Malaria Manufacturer Market Share

3.4.2 Top 5 Drugs for Malaria Manufacturer Market Share

3.5 Market Competition Trend

4 United States Drugs for Malaria Market Analysis by States

4.1 United States Drugs for Malaria Sales Market Share by States

4.2 United States Drugs for Malaria Sales by States (2012-2017)

4.3 United States Drugs for Malaria Revenue (Value) by States (2012-2017)

5 United States Market Segmentation Drugs for Malaria by Type

5.1 United States Drugs for Malaria Sales, Revenue and Market Share by Type (2012-2017)

5.1.1 United States Drugs for Malaria Sales and Market Share by Type (2012-2017)

5.1.2 United States Drugs for Malaria Revenue and Market Share by Type (2012-2017)

5.2 Aryl Aminoalcohol Compounds Sales Growth and Price

5.2.1 United States Aryl Aminoalcohol Compounds Sales Growth (2012-2017)

5.2.2 United States Aryl Aminoalcohol Compounds Price (2012-2017)

5.3 Antifolate Compounds Sales Growth and Price

5.3.1 United States Antifolate Compounds Sales Growth (2012-2017)

5.3.2 United States Antifolate Compounds Price (2012-2017)

5.4 Artemisinin Compounds Sales Growth and Price

5.4.1 United States Artemisinin Compounds Sales Growth (2012-2017)

5.4.2 United States Artemisinin Compounds Price (2012-2017)

6 United States Market Segmentation Drugs for Malaria by Application

6.1 United States Drugs for Malaria Sales Market Share by Application (2012-2017)

6.2 Prevention Sales Growth (2012-2017)

6.3 Treatment Sales Growth (2012-2017)

6.4 Other Sales Growth (2012-2017)

7 California Drugs for Malaria Sales, Revenue, by Type, Application and Manufacturers

7.1 California Drugs for Malaria Revenue, Sales and Growth Rate (2012-2017)

7.2 California Drugs for Malaria Sales and Market Share by Type

7.3 California Drugs for Malaria Sales by Application (2012-2017)

8 New York Drugs for Malaria Sales, Revenue, by Type, Application and Manufacturers

8.1 New York Drugs for Malaria Revenue, Sales and Growth Rate (2012-2017)

8.2 New York Drugs for Malaria Sales and Market Share by Type

8.3 New York Drugs for Malaria Sales by Application (2012-2017)

9 Texas Drugs for Malaria Sales, Revenue, by Type, Application and Manufacturers

9.1 Texas Drugs for Malaria Revenue, Sales and Growth Rate (2012-2017)

9.2 Texas Drugs for Malaria Sales and Market Share by Type

9.3 Texas Drugs for Malaria Sales by Application (2012-2017)

10 Florida Drugs for Malaria Sales, Revenue, by Type, Application and Manufacturers

10.1 Florida Drugs for Malaria Revenue, Sales and Growth Rate (2012-2017)

10.2 Florida Drugs for Malaria Sales and Market Share by Type

10.3 Florida Drugs for Malaria Sales by Application (2012-2017)

11 Illinois Drugs for Malaria Sales, Revenue, by Type, Application and Manufacturers

11.1 Illinois Drugs for Malaria Revenue, Sales and Growth Rate (2012-2017)

11.2 Illinois Drugs for Malaria Sales and Market Share by Type

11.3 Illinois Drugs for Malaria Sales by Application (2012-2017)

12 Drugs for Malaria Market Forecast (2017-2022)

12.1 United States Drugs for Malaria Sales, Revenue and Growth Rate (2017-2022)

12.2 Drugs for Malaria Market Forecast by States (2017-2022)

12.3 Drugs for Malaria Market Forecast by Type (2017-2022)

12.4 Drugs for Malaria Market Forecast by Application (2017-2022)

13 Drugs for Malaria Manufacturing Cost Analysis

13.1 Drugs for Malaria Key Raw Materials Analysis

13.1.1 Key Raw Materials

13.1.2 Price Trend of Key Raw Materials

13.1.3 Key Suppliers of Raw Materials

13.1.4 Market Concentration Rate of Raw Materials

13.2 Proportion of Manufacturing Cost Structure

13.2.1 Raw Materials

13.2.2 Labor Cost

13.2.3 Manufacturing Expenses

13.3 Manufacturing Process Analysis of Drugs for Malaria

14 Industrial Chain, Sourcing Strategy and Downstream Buyers

14.1 Drugs for Malaria Industrial Chain Analysis

14.2 Upstream Raw Materials Sourcing

14.3 Raw Materials Sources of Drugs for Malaria Major Manufacturers in 2016

14.4 Downstream Buyers

15 Sales Channel, Distributors, Traders and Dealers

15.1 Sales Channel

15.1.1 Direct Marketing

15.1.2 Indirect Marketing

15.1.3 Marketing Channel Future Trend

15.2 Distributors, Traders and Dealers

16 Research Findings and Conclusion

17 Appendix

17.1 Methodology

17.2 Analyst Introduction

17.3 Data Source

List of Tables and Figures

Figure Drugs for Malaria Picture

Table Product Specifications of Drugs for Malaria

Figure United States Sales Market Share of Drugs for Malaria by Types in 2016

Table Types of Drugs for Malaria

Figure Aryl Aminoalcohol Compounds Picture

Table Major Manufacturers of Aryl Aminoalcohol Compounds

Figure Antifolate Compounds Picture

Table Major Manufacturers of Antifolate Compounds

Figure Artemisinin Compounds Picture

Table Major Manufacturers of Artemisinin Compounds

Table United States Drugs for Malaria Sales Market Share by Applications in 2016

Table Applications of Drugs for Malaria

Figure Prevention Picture

Figure Treatment Picture

Figure Other Picture

Figure California Drugs for Malaria Revenue (Million USD) and Growth Rate (2012-2022)

Figure Texas Drugs for Malaria Revenue (Million USD) and Growth Rate (2012-2022)

Figure New York Drugs for Malaria Revenue (Million USD) and Growth Rate (2012-2022)

Figure Florida Drugs for Malaria Revenue (Million USD) and Growth Rate (2012-2022)

Figure Illinois Drugs for Malaria Revenue (Million USD) and Growth Rate (2012-2022)

Table Cipla Basic Information, Manufacturing Base and Competitors

Table Cipla Drugs for Malaria Type and Applications

Table Cipla Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Guilin Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table Guilin Pharmaceutical Drugs for Malaria Type and Applications

Table Guilin Pharmaceutical Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table IPCA Laboratories Basic Information, Manufacturing Base and Competitors

Table IPCA Laboratories Drugs for Malaria Type and Applications

Table IPCA Laboratories Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors

Table GlaxoSmithKline Drugs for Malaria Type and Applications

Table GlaxoSmithKline Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Mylan Labs Basic Information, Manufacturing Base and Competitors

Table Mylan Labs Drugs for Malaria Type and Applications

Table Mylan Labs Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Roche Basic Information, Manufacturing Base and Competitors

Table Roche Drugs for Malaria Type and Applications

Table Roche Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Novartis Basic Information, Manufacturing Base and Competitors

Table Novartis Drugs for Malaria Type and Applications

Table Novartis Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Sanofi Aventis Basic Information, Manufacturing Base and Competitors

Table Sanofi Aventis Drugs for Malaria Type and Applications

Table Sanofi Aventis Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Ajanta Pharma Basic Information, Manufacturing Base and Competitors

Table Ajanta Pharma Drugs for Malaria Type and Applications

Table Ajanta Pharma Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table United States Drugs for Malaria Sales by Manufacturer (2016-2017)

Figure United States Drugs for Malaria Sales Market Share by Manufacturer in 2016

Figure United States Drugs for Malaria Sales Market Share by Manufacturer in 2017

Table United States Drugs for Malaria Revenue by Manufacturer (2016-2017)

Figure United States Drugs for Malaria Revenue Market Share by Manufacturer in 2015

Figure United States Drugs for Malaria Revenue Market Share by Manufacturer in 2016

Table United States Drugs for Malaria Price by Manufacturers (2016-2017)

Figure Top 3 Drugs for Malaria Manufacturer Market Share in 2016

Figure Top 3 Drugs for Malaria Manufacturer Market Share in 2017

Figure Top 5 Drugs for Malaria Manufacturer Market Share in 2016

Figure Top 5 Drugs for Malaria Manufacturer Market Share in 2017

Figure United States Drugs for Malaria Sales and Growth (2012-2017)

Table United States Drugs for Malaria Sales by States (2012-2017)

Table United States Drugs for Malaria Sales Market Share by States (2012-2017)

Figure United States 2012 Drugs for Malaria Sales Market Share by States

Figure United States 2016 Drugs for Malaria Sales Market Share by States

Figure United States Drugs for Malaria Revenue and Growth (2012-2017)

Table United States Drugs for Malaria Revenue by States (2012-2017)

Table United States Drugs for Malaria Revenue Market Share by States (2012-2017)

Table United States 2012 Drugs for Malaria Revenue Market Share by States

Table United States 2016 Drugs for Malaria Revenue Market Share by States

Table United States Drugs for Malaria Sales by Type (2012-2017)

Table United States Drugs for Malaria Sales Share by Type (2012-2017)

Table United States Drugs for Malaria Revenue by Type (2012-2017)

Table United States Drugs for Malaria Revenue Share by Type (2012-2017)

Figure United States Aryl Aminoalcohol Compounds Sales Growth (2012-2017)

Figure United States Aryl Aminoalcohol Compounds Price (2012-2017)

Figure United States Antifolate Compounds Sales Growth (2012-2017)

Figure United States Antifolate Compounds Price (2012-2017)

Figure United States Artemisinin Compounds Sales Growth (2012-2017)

Figure United States Artemisinin Compounds Price (2012-2017)

Table United States Drugs for Malaria Sales by Application (2012-2017)

Table United States Drugs for Malaria Sales Share by Application (2012-2017)

Figure United States Prevention Sales Growth (2012-2017)

Figure United States Treatment Sales Growth (2012-2017)

Figure United States Other Sales Growth (2012-2017)

Figure California Drugs for Malaria Revenue and Growth (2012-2017)

Figure California Drugs for Malaria Sales and Growth (2012-2017)

Table California Drugs for Malaria Sales by Type (2012-2017)

Table California Drugs for Malaria Sales Market Share by Type (2012-2017)

Table California Drugs for Malaria Sales by Application (2012-2017)

Table California Drugs for Malaria Sales Market Share by Application (2012-2017)

Figure New York Drugs for Malaria Revenue and Growth (2012-2017)

Figure New York Drugs for Malaria Sales and Growth (2012-2017)

Table New York Drugs for Malaria Sales by Type (2012-2017)

Table New York Drugs for Malaria Sales Market Share by Type (2012-2017)

Table New York Drugs for Malaria Sales by Application (2012-2017)

Table New York Drugs for Malaria Sales Market Share by Application (2012-2017)

Figure Texas Drugs for Malaria Revenue and Growth (2012-2017)

Figure Texas Drugs for Malaria Sales and Growth (2012-2017)

Table Texas Drugs for Malaria Sales by Type (2012-2017)

Table Texas Drugs for Malaria Sales Market Share by Type (2012-2017)

Table Texas Drugs for Malaria Sales by Application (2012-2017)

Table Texas Drugs for Malaria Sales Market Share by Application (2012-2017)

Figure Florida Drugs for Malaria Revenue and Growth (2012-2017)

Figure Florida Drugs for Malaria Sales and Growth (2012-2017)

Table Florida Drugs for Malaria Sales by Type (2012-2017)

Table Florida Drugs for Malaria Sales Market Share by Type (2012-2017)

Table Florida Drugs for Malaria Sales by Application (2012-2017)

Table Florida Drugs for Malaria Sales Market Share by Application (2012-2017)

Figure Illinois Drugs for Malaria Revenue and Growth (2012-2017)

Figure Illinois Drugs for Malaria Sales and Growth (2012-2017)

Table Illinois Drugs for Malaria Sales by Type (2012-2017)

Table Illinois Drugs for Malaria Sales Market Share by Type (2012-2017)

Table Illinois Drugs for Malaria Sales by Application (2012-2017)

Table Illinois Drugs for Malaria Sales Market Share by Application (2012-2017)

Figure United States Drugs for Malaria Sales, Revenue and Growth Rate (2017-2022)

Table United States Drugs for Malaria Sales Forecast by States (2017-2022)

Table United States Drugs for Malaria Market Share Forecast by States (2017-2022)

Table United States Drugs for Malaria Sales Forecast by Type (2017-2022)

Table United States Drugs for Malaria Market Share Forecast by Type (2017-2022)

Table United States Drugs for Malaria Sales Forecast by Application (2017-2022)

Table United States Drugs for Malaria Market Share Forecast by Application (2017-2022)

Table Sales Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Drugs for Malaria

Figure Manufacturing Process Analysis of Drugs for Malaria

Figure Drugs for Malaria Industrial Chain Analysis

Table Raw Materials Sources of Drugs for Malaria Major Manufacturers in 2016

Table Major Buyers of Drugs for Malaria

Table Distributors/Traders/ Dealers List

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370